Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer

Published:2023-02 Issue:2 Volume:83 Page:112-120
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Barnett Ethan S.,Schultz Nikolaus,Stopsack Konrad H.,Lam Ernest T.,Arfe Andrea,Lee Jerry,Zhao Jimmy L.,Schonhoft Joseph D.,Carbone Emily A.,Keegan Niamh M.,Wibmer Andreas,Wang Yipeng,Solit David B.,Abida Wassim,Wenstrup Richard,Scher Howard I.

Funder

National Cancer Institute

Sidney Kimmel Center for Prostate and Urologic Cancers

Marie-Josée and Henry R. Kravis Center for Molecular Oncology

U.S. Department of Defense

Publisher

Elsevier BV

Subject

Urology

Reference36 articles.

1. Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration;Abida;J Clin Oncol,2020

2. Olaparib for metastatic castration-resistant prostate cancer;de Bono;N Engl J Med,2020

3. Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making;Abida;JCO Precis Oncol,2017

4. Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer—a Cancer and Leukemia Group B study;Ross;Clin Cancer Res,2005

5. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine;Sailer;Cancer,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a circulating tumor cells-related signature focusing on biochemical recurrence and immunotherapy response in prostate cancer;Heliyon;2023-12

2. OCT4‑positive circulating tumor cells may predict a poor prognosis in patients with metastatic castration‑resistant prostate cancer treated with abiraterone plus prednisone therapy;Oncology Letters;2023-09-04

3. Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer;The Cancer Journal;2023-07

4. Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?;European Urology;2023-02

5. Circulating tumor cells: Biological features and survival mechanisms;BIOCELL;2023